PBA

Paradigm Biocapital Advisors Portfolio holdings

AUM $2.34B
This Quarter Return
+2.84%
1 Year Return
+13.3%
3 Year Return
+245.82%
5 Year Return
–
10 Year Return
–
AUM
$2.34B
AUM Growth
+$2.34B
Cap. Flow
+$178M
Cap. Flow %
7.61%
Top 10 Hldgs %
72.34%
Holding
33
New
6
Increased
14
Reduced
5
Closed
5

Top Buys

1
SRRK icon
Scholar Rock
SRRK
$56.7M
2
PCVX icon
Vaxcyte
PCVX
$54.5M
3
MRUS icon
Merus
MRUS
$48M
4
BBIO icon
BridgeBio Pharma
BBIO
$41.7M
5
ALKS icon
Alkermes
ALKS
$39.4M

Top Sells

1
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
$77M
2
ARGX icon
argenx
ARGX
$35.3M
3
CYTK icon
Cytokinetics
CYTK
$34.5M
4
INSM icon
Insmed
INSM
$34.4M
5
MTSR
Metsera, Inc. Common Stock
MTSR
$32.4M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
IMTX icon
26
Immatics
IMTX
$649M
$16.9M 0.72%
3,144,157
+1,237,049
+65% +$6.66M
ERAS icon
27
Erasca
ERAS
$454M
$15.1M 0.65%
11,907,182
+1,104,828
+10% +$1.4M
CBIO
28
Crescent Biopharma, Inc. Common Stock
CBIO
$200M
$10.4M 0.44%
+642,721
New +$10.4M
ARGX icon
29
argenx
ARGX
$43.6B
– –
-59,679
Closed -$35.3M
ARQT icon
30
Arcutis Biotherapeutics
ARQT
$1.86B
– –
-1,465,334
Closed -$22.9M
CYTK icon
31
Cytokinetics
CYTK
$5.94B
– –
-858,664
Closed -$34.5M
INSM icon
32
Insmed
INSM
$28.8B
– –
-451,359
Closed -$34.4M
MTSR
33
Metsera, Inc. Common Stock
MTSR
$3.8B
– –
-1,191,462
Closed -$32.4M
1
2